Course Information
UCLA Heart Failure Symposium 2020: State-of-the-Art Updates & Therapies for Advanced Heart Failure

The Ritz-Carlton, Marina del Rey
Marina del Rey, California
MOVED TO SATURDAY, MAY 22, 2021
May 02, 2020


Download: [ PDF ]

Course Description

Heart failure affects approximately six million Americans and is the most common diagnosis for acute hospitalization in patients over 65 years. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from advanced therapies for complex cardiac disease. Academic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. UCLA Health wants to enhance the role of the primary care physician and primary cardiologist as the central provider for continuity of care for these complex heart failure patients. 

The Ninth Annual UCLA Heart Failure Symposium 2020 will: 

  1. Discuss general heart failure treatment options including short and long term mechanical circulatory support therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous and structural interventions, and complex congenital heart disease management.
  2. Emphasize the need for developing networks linking academic centers with community physicians to manage these patients through the evolution of their disease pre and post advanced cardiac intervention.
  3. Discuss heart failure therapies in cardio-oncology, amyloidosis and new medication updates, as well as address patient and care-provider’s specific needs and perspectives.

Target Audience

Family practitioners, internists, cardiologists, pediatricians, nurses and all other healthcare professionals taking care of heart failure patients, as well as the interested lay public.

Registration Information

Enrollment

To enroll click here.

By Mail

Send the completed enrollment form to:

David Geffen School of Medicine at UCLA
Office of Continuing Medical Education

UCLA Heart Failure Symposium
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512

By Fax

Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.

By Phone

Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620

Course Fees

  • Pre-registration: $75
  • On-site registration: $100

Tuition includes registration in the symposium, syllabus, continental breakfast, lunch and coffee breaks

Faculty

COURSE DIRECTOR

Ali Nsair, MD
Medical Director, Heart Transplantation and Mechanical Circulatory Support Device Services
Heart Failure
Interventional Cardiology
Broad Stem Cell Research Center

UCLA COURSE FACULTY AND PANEL PARTICIPANTS

Jamil Aboulhosn, MD, FACC
Professor of Clinical Medicine and Pediatrics
Director, Ahmanson/UCLA Adult Congenital Heart Disease Center

Olcay Aksoy, MD, FACC
Assistant Clinical Professor
Interventional Cardiology
UCLA Cardiovascular Medicine

Farah Al-Saffar, MD
Cardiology Fellow
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Abbas Ardehali, MD, FACS
Professor of Surgery and Medicine
Division of Cardiothoracic Surgery
William E. Connor Chair in Cardiothoracic Transplantation 
Director, UCLA Heart, Lung, and Heart-Lung Transplant Programs

Arnold S. Baas, MD, FACC, FACP
Professor of Medicine
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Jason Bradfield, MD, FACC, FHRS
Associate Professor of Medicine
Director, Specialized Program for Ventricular Tachycardia 
UCLA Cardiac Arrhythmia Center

Marcella Calfon-Press, MD, PhD, FACC
Assistant Clinical Professor
Interventional Cardiology
Co-Director, UCLA Barbra Streisand Women’s Heart Health Program
Associate Program Director, Interventional Cardiology Fellowship

Julie W. Creaser, RN, MN, CNS, CHFN
Advanced Practice Nurse, Ahmanson-UCLA Cardiomyopathy Center

Daniel Cruz, MD, PhD
Associate Clinical Professor of Medicine
Associate Director, Heart Transplant
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Ravi H. Dave, MD 
Director of Interventional Cardiology at UCLA Health
Program Director of the Interventional Cardiology Fellowship Program
Director of the Cardiac Catheterization Laboratories at Santa Monica UCLA Medical Center and Community Cardiology Practices

Mario Deng, MD, FACC, FESC
Professor of Medicine
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Gregg C. Fonarow, MD, FACC, FAHA, FHFSA
Chief, UCLA Division of Cardiology
Director, Ahmanson-UCLA Cardiomyopathy Center
Co-Director, UCLA Preventative Cardiology Program
The Eliot Corday Chair in Cardiovascular Medicine and Science

Janet K. Han, MD, FACC, FHRS
Associate Professor of Medicine
Assistant Director, Cardiac Arrhythmia Service, VAGLAHS
Associate Program Director, Fellowship in Cardiovascular Diseases, UCLA/VAGLAHS/Olive View Medical Center
VA Greater Los Angeles Healthcare System

Jeffrey J. Hsu, MD, PhD
Cardiology Fellow
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Megan Kamath, MD
Clinical Instructor, Medicine/Cardiology
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Murray H. Kwon, MD, MBA 
Associate Clinical Professor
UCLA Division of Cardiac Surgery

Codie Lieto, LCSW
Clinical Social Worker
UCLA Advance Care Planning & Palliative Care
Department of Care Coordination and Clinical Social Work

Melissa A Moore, RN, BSN, CCTC 
UCLA Heart Transplant Coordinator
Outreach Coordinator for Advanced Cardiac Therapies

Rushi Parikh, MD
Assistant Clinical Professor
UCLA Interventional Cardiology & Advanced Heart Failure

Anca Rahman, RN, MSN, NP-C
Advanced Practice Nurse, Ahmanson-UCLA Cardiomyopathy Center

Rajan Saggar, MD
Associate Professor of Medicine
Director, Medical Intensive Care Unit
Lung and Heart-Lung Transplant and Pulmonary Hypertension Programs

Richard J. Shemin, MD, FACC
Robert and Kelly Day Professor and Chief Cardiothoracic Surgery
UCLA Executive Vice Chairman of Surgery
Co-Director of the Cardiovascular Center

Emily Stimpson, RN, MSN, CCTC
UCLA Heart and Lung Transplant Nurse Manager

Darko Vucicevic, MD
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Eric H. Yang, MD, FACC, FASE
Associate Clinical Professor of Medicine
Director, UCLA Cardio-Oncology Program
Associate Program Director, UCLA/Olive View/West LA VA Cardiovascular Diseases Fellowship

Program Agenda

Saturday, May 22, 2021

7:45 Welcome and Introduction
Ali Nsair, MD
ADVANCED HEART FAILURE: Management and Treatment Updates
Moderators: Jeff Hsu, MD, PhD and Julie Creaser, RN, MN, CNS, CHFN
8:00 State-of-the-Art Medical Therapies in Advanced Heart Failure: What is New in 2020
Gregg Fonarow, MD, FACC, FAHA, FHFSA
8:20 Heart and Heart-Lung Transplantation Updates
Abbas Ardehali, MD, FACS
8:40 Working in Sync: Device Therapy and Arrhythmia Management
Jason Bradfield, MD
9:00 Pulmonary Hypertension Management: From Surgical Interventions to Medical Therapies
Rajan Saggar, MD

9:20

Cardiac Amyloidosis and the Evolution of Treatment Options
Megan Kamath, MD

9:40 Patient Selection for Advanced Therapies in Heart Failure
Arnold Baas, MD, FACC, FACP
10:00 Break
STRUCTURAL INTERVENTIONS AND MECHANICAL CIRCULATORY SUPPORT THERAPIES: State-of-the-Art Advancements
Moderators: Rushi Parikh, MD and Emily Stimpson, RN, MSN, CCTC
10:20 Durable Left Ventricular Assist Devices, Current Therapies and New Advancements
Murray Kwon, MD, MBA
10:40 Minimally Invasive Surgical interventions for Valvular Heart Disease: Robotics and Beyond
Richard Shemin, MD, FACC
11:00 Functional and Degenerative Mitral Regurgitation: MitraClip and New Therapies
Marcella Calfon-Press, MD, PhD, FACC
11:20 Aortic Stenosis in the Era of Low Risk TAVR: Updates and Future Directions in Heart Failure Patients
Olcay Aksoy, MD, FACC
11:40 Adult Congenital Heart Disease Management: Medical Therapies and Structural Interventions
Jamil Aboulhosn, MD, FACC
12:00 When is Revascularization Complete: PCI in Multi-Vessel Coronary Artery Disease
Ravi Dave, MD
12:20 Cardiogenic Shock: The Rising Role of Temporary Mechanical Circulatory Support
Ali Nsair, MD
12:40 Lunch
MULTIDISCIPLINARY APPROACH TO PATIENT OPTIMIZATION
Moderators: Darko Vucicevic, MD and Farah Al-Saffar, MD
2:00 The Patient Perspective
Mario Deng, MD, FACC, FESC, and Codie Lieto, LCSW
2:30 Remote Monitoring in Advanced Heart Failure with CardioMEMS: Case Series
Daniel Cruz, MD, PhD
2:50 Practical Tips on Implementing the Latest Heart Failure Therapies
Julie Creaser, RN, MN, CNS, CHFN, and Anca Rahman, RN, MSN, NP-C
3:10 Cardio-Oncology: A New Frontier for a Growing Patient Population.
Eric Yang, MD, FACC, FASE
3:30 Wearables and Smart Devices for AFib: Past, Present and Future
Janet Han, MD, FACC, FHRS
3:50 Expanding Patient Access: Shared Care and Growing Collaboration with the Community
Melissa Moore, RN, BSN, CCTC
4:00 Reception and Adjournment

Objectives

At the conclusion of the program participants will be able to:

  • Identify the epidemiology and pathophysiology of heart failure and the need for mechanical circulatory support with a growing heart failure population.
  • Identify indications for and management of lifelong left ventricular assist device therapy.
  • Implement shared care programs with the community and co-manage patients in need of complex cardiac therapies including LVAD therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous interventions, and complex congenital heart disease management.
  • Discuss the comprehensive multidisciplinary care and services available to complex cardiac patients within the UCLA Heart Failure Program.

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

Disclosures

The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.

Miscellaneous

LOCATION

The Ritz-Carlton, Marina del Rey
Salon 1 & 2 Ballroom
4375 Admiralty Way
Marina Del Rey, CA 90292
(310) 823-1700

PARKING

Valet parking $15